Recruiting
An In-situ Detection for MicroRNA
We designed a new in-site detection method for MicroRNA in the serum of patients with breast cancer.
ClinicalTrials.gov IDNCT06529614
PhaseNot Applicable
Enrollment100
SponsorTongji Hospital
Age18 Years and older
SexFEMALE
Conditions studied
Breast Cancer
About this study
We designed a new in-site detection method for MicroRNA in the serum of patients with breast cancer.
Interventions
- Other: In-situ detection for Micro-RNA — a new in-situ detection methods for Micro-RNA
Primary outcomes
- Sensitivity and specificity of test (8 months)
Eligibility information
Inclusion Criteria: Healthy without serious diseases
\-
Exclusion Criteria:
* situations that may affect the results
Study locations
- Tongji Hospital, Wuhan, Hubei 430030 China
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.